TrialSupportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer2012

Aprepitant for prevention of nausea and vomiting secondary to high-dose cyclophosphamide administered to patients undergoing autologous peripheral blood stem cells mobilization: a phase II trial.

Muneer H Abidi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.